Legislation introduced to ensure accountability in DEA quotas for Rx opioid painkillers
WASHINGTON – For 2019, the Drug Enforcement Administration (DEA) has approved the manufacture of the equivalent of almost eight billion 10-milligram pills of OxyContin.